Cefozopran hydrochloride|113981-44-5|(盐酸头孢唑兰; SCE-2787 hydrochloride)-陌孚医药/Medlife

您当前的位置：

Cefozopran hydrochloride (Synonyms: 盐酸头孢唑兰; SCE-2787 hydrochloride)

目录号: PL14676 纯度: ≥95%

CAS No. :113981-44-5

商品编号	规格	价格	会员价
PL14676-50mg	50mg	¥2828.00	请登录
PL14676-100mg	100mg	¥4275.00	请登录
PL14676-200mg	200mg	询价	询价
PL14676-500mg	500mg	询价	询价
PL14676-10mM*1mLinDMSO	10mM*1mLinDMSO	¥3111.00	请登录

Medlife所售产品仅用于科学研究（非临床研究），非药品不可食用，不可用于人体或动物的临床诊断和治疗，我们不为个人提供产品及服务。产品COA等资料，可至下方“质量控制”中下载。

加入购物车在线咨询收藏产品大包装询价

中文名称	Cefozopran hydrochloride
中文别名	盐酸头孢唑兰;1-[[(6R,7R)-7-[(Z)-2-(5-氨基-1,2,4-噻二唑-3-基)-2-甲氧亚氨基乙酰胺基]-2-羧基-8-氧代-5-硫杂-1-氮杂双环[4.2.0]辛-2-烯-3-基]甲基]咪唑并[1,2-b]哒嗪鎓内盐盐酸盐;1-[[(6R,7R)-7-[(Z)-2-(5-氨基-1,2,4-噻二唑-3-基)-2-甲氧亚氨基乙酰胺基]-2-羧基-8-氧代-5-硫杂-1-氮杂双环[4.2.0];吡唑磷;盐酸头孢唑兰中间体;1-[[(6R,7R)-7-[(Z)-2-(5-氨基-1,2,4-噻二唑-3-基)-2-甲氧亚氨基乙酰胺基]-2-羧基-8-氧代-5-硫杂-1-氮杂双环[4.2.0]辛-2-烯-3-基]甲基]咪唑并[1,2-B]哒嗪内盐盐酸盐;头孢唑兰盐酸盐
英文名称	Cefozopran hydrochloride
英文别名	Cefozopran hydrochloride;(6R,7R)-7-[[(2E)-2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-methoxyiminoacetyl]amino]-3-(imidazo[2,3-f]pyridazin-4-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid chloride;Cefozopran HCl;N-BOC-4-Hydroxypiperidine;SCE-2787 hydrochloride;Cefozopran hydrochlo;cefozopran monohydrochloride;Czop;D02233;Cefozopran hydrochloride (jp15)
Cas No.	113981-44-5
分子式	C₁₉H₁₇N₉O₅S₂^.HCl
分子量	551.99
包装储存	-20°C, sealed storage, away from moistur In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

产品详情	Cefozopran (SCE-2787) hydrochloride 是一种半合成的、非肠道的、第四代头孢菌素。Cefozopran hydrochloride，作为一种抗生素，具有广谱抗菌活性，能抑制大多数革兰氏阴性和革兰氏阳性菌。
生物活性	Cefozopran (SCE-2787) hydrochloride is a semi-synthetic, parenteral, fourth-generation cephalosporin. Cefozopran hydrochloride, an antibiotic, has a broad spectrum of antibacterial activity, inhibiting most of the gram-negative and gram-positive organisms.
性状	Solid
体外研究(In Vitro)	Cefozopran (SCE-2787) is a fourth-generation cephalosporin that has good activity against gram-positive organisms including methicillin-susceptible staphylococci, enterococci, and viridans group streptococci; and against gram-negative organisms including hemophilus influenza. Moreover, cefozopran has comparatively good activity against enterococci and P. aeruginosa , which are refractory to other cephalosporins. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)	Cefozopran (SCE-2787) (5-80 mg/kg; s.c.; twice a day for 5 days; four-week-old ICR male mice) is effective against acute respiratory tract infections caused by Kiebsiella pneumonia DT-S. In the model of chronic respiratory tract infection caused by K. pneumoniae 27, Cefozopran (20-80 mg/kg; s.c.; twice a day for 7 days; five-week-old CBA/J female mice) is as effective as Ceftazidime. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件	Room temperature in continental US; may vary elsewhere.
储存方式	-20°C, sealed storage, away from moistur In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
参考文献	[1]. Sato T, et al. A prospective, randomized study comparing cefozopran with piperacillin-tazobactam plus ceftazidime as empirical therapy for febrile neutropenia in children with hematological disorders. Pediatr Blood Cancer. 2008;51(6):774-777. [2]. Iizawa Y, et al. Therapeutic effect of cefozopran (SCE-2787), a new parenteral cephalosporin, against experimental infections in mice. Antimicrob Agents Chemother. 1993;37(1):100-105.

溶解度数据	In Vitro: DMSO : 100 mg/mL (181.16 mM; Need ultrasonic)H₂O : ≥ 52 mg/mL (94.20 mM)

搜索质检报告(COA)

产品使用指南

Data Sheet

1：一般建议：溶解度为Medlife测试数据，可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解，请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异，仅做参考，具体以实验方案为准。

2：储存条件：粉末-20°C一般情况可以保存3年，溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异，请细致阅读产品信息，并辅助参考相关文献描述。

相关产品

The molarity calculator equation

The dilution calculator equation